Core Viewpoint - Lifevantage (LFVN) reported quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.22 per share, representing a -31.82% earnings surprise [1] - The company also posted revenues of $48.93 million for the quarter, missing the Zacks Consensus Estimate by 10.62% and down from $67.76 million a year ago [2] Company Performance - Over the last four quarters, Lifevantage has surpassed consensus EPS estimates only once [2] - The stock has underperformed, losing about 13% since the beginning of the year compared to the S&P 500's gain of 1.1% [3] Future Outlook - The company's earnings outlook will be crucial for investors, including current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the next quarter is $0.34 on revenues of $61.69 million, and for the current fiscal year, it is $1.06 on revenues of $226.02 million [7] Industry Context - Lifevantage belongs to the Zacks Medical - Dental Supplies industry, which is currently in the top 40% of over 250 Zacks industries [8] - The performance of Lifevantage's stock may be influenced by the overall outlook for the industry [8]